The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended on Friday 26 March the approval of two production sites for Covid-19 vaccines.
Based in Leiden (Netherlands), the Halix site brings the number of AstraZeneca’s vaccine production sites in the European Union to four. The other approved site is in Marburg, Germany, and will be used to produce BioNTech/Pfizer’s Covid-19 vaccine, bringing the number of licenced sites in the EU to...